Clinical Drug Experience Knowledgebase

alemtuzumab (campath) (1 trial)

bleomycin (blenoxane) (1 trial)

cyclophosphamide (cytoxan) (7 trials)

dacarbazine (dtic-dome) (1 trial)

doxorubicin (Doxil) (7 trials)

etoposide (vepesid) (4 trials)

Filgrastim (neupogen) (1 trial)

fludarabine (fludara) (1 trial)

interferon alpha-2a (roferon-a) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

polatuzumab vedotin (Polivy) (1 trial)

prednisone (meticorten) (7 trials)

procarbazine (matulane) (1 trial)

rituximab (rituxan) (9 trials)

sargramostim (leukine) (2 trials)

vinblastine (velban) (1 trial)

vincristine (oncovin) (7 trials)

acalabrutinib (calquence) (1 trial)

ancestim (1 trial)

cytarabine (cytosar-u) (1 trial)

ibritumomab tiuxetan (Zevalin) (1 trial)

ibrutinib (imbruvica) (3 trials)

idelalisib (zydelig) (1 trial)

lenalidomide (revlimid) (1 trial)

obinutuzumab (gazyva) (1 trial)

venetoclax (venclexta) (2 trials)